Bringing hope
to people living with Alzheimer’s disease and ALS

Investor Presentation

Latest News Release

Alpha Cognition Announces Mr. Michael McFadden as Chief Executive Officer and Realignment of Leadership Team for Next Stage of ALPHA-1062 Drug Development

Treatments

Alzheimers: ALPHA-1062

A New Approach

Quick Links

About ACI
ALPHA-0602
Team
Contact

Latest News

View All

Alpha Cognition Announces Mr. Michael McFadden as Chief Executive Officer and Realignment of Leadership Team for Next Stage of ALPHA-1062 Drug Development

Alpha Cognition Presenting at the Benzinga Biotech Small Cap Conference

View All

TSX-V: ACOG

15 min delay

Last$1.05

Change$0.05

Open1.05

Vol7,000

High1.05

Low1.05

Stock Information